Literature DB >> 23922369

CD8 T cell exhaustion in human visceral leishmaniasis.

Shalini Gautam1, Rajiv Kumar, Neetu Singh, Abhishek Kumar Singh, Madhukar Rai, David Sacks, Shyam Sundar, Susanne Nylén.   

Abstract

Little is known about CD8 T cells in human visceral leishmaniasis (VL) and it is unclear if these cells have a protective, pathological and/or suppressive function. In experimental VL CD8 T cells have been shown to contribute to parasite control and play an important role in vaccine-generated immunity. To better understand the role of CD8 T cells in human VL, we examined molecules associated with anergy and cytotoxic T lymphocytes (CTL) in peripheral blood mononuclear cells (PBMC) and splenic aspirates (SA), and in CD8 cells derived from these tissues. Gene and surface marker expression suggest that splenic CD8 cell predominantly display an anergic phenotype, whereas CD8-PBMC have features of both anergic cells and CTLs. CD8 cells contribute to the baseline IFNγ levels in whole blood (WB) and SA cultures, but not to the Leishmania induced IFNγ release that is revealed using WB cultures. Blockade of CTLA-4 or PD1 had no effect on IFNγ production or parasite survival in SA cultures. Following cure, CD8 T cells contribute to the Leishmania induced IFNγ production observed in Leishmania stimulated cell cultures. We suggest CD8 T cells are driven to anergy/exhaustion in human VL, which affect their ability to contribute to protective immune responses.

Entities:  

Keywords:  CD8 T cell; CTLA-4; IL-10; PBMC; PD1; Visceral leishmaniasis; spleen

Mesh:

Substances:

Year:  2013        PMID: 23922369      PMCID: PMC3873784          DOI: 10.1093/infdis/jit401

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis.

Authors:  S Stäger; D F Smith; P M Kaye
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

Review 2.  Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.

Authors:  Lieping Chen
Journal:  Nat Rev Immunol       Date:  2004-05       Impact factor: 53.106

3.  Immunotherapy with OX40L-Fc or anti-CTLA-4 enhances local tissue responses and killing of Leishmania donovani.

Authors:  Soombul Zubairi; Stephanie L Sanos; Sue Hill; Paul M Kaye
Journal:  Eur J Immunol       Date:  2004-05       Impact factor: 5.532

4.  Analysis of granzyme B activity as a surrogate marker of Leishmania-specific cell-mediated cytotoxicity in zoonotic cutaneous leishmaniasis.

Authors:  Thouraya Bousoffara; Hechmi Louzir; Afif Ben Salah; Koussay Dellagi
Journal:  J Infect Dis       Date:  2004-03-12       Impact factor: 5.226

5.  Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes.

Authors:  P Costa; S Rusconi; D Mavilio; M Fogli; G Murdaca; D Pende; M C Mingari; M Galli; L Moretta; A De Maria
Journal:  AIDS       Date:  2001-05-25       Impact factor: 4.177

6.  An analysis of T cell responsiveness in Indian kala-azar.

Authors:  D L Sacks; S L Lal; S N Shrivastava; J Blackwell; F A Neva
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

7.  Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gamma.

Authors:  S Nylén; K Maasho; K Söderstrom; T Ilg; H Akuffo
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

8.  CD8(+) T cells with parasite-specific cytotoxic activity and a Tc1 profile of cytokine and chemokine secretion develop in experimental visceral leishmaniasis.

Authors:  Panagiotis Tsagozis; Evdokia Karagouni; Eleni Dotsika
Journal:  Parasite Immunol       Date:  2003 Nov-Dec       Impact factor: 2.280

9.  Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.

Authors:  J J Stern; M J Oca; B Y Rubin; S L Anderson; H W Murray
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

10.  Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patients.

Authors:  Paola Costa; Stefano Rusconi; Manuela Fogli; Domenico Mavilio; Giuseppe Murdaca; Francesco Puppo; Maria Cristina Mingari; Massimo Galli; Lorenzo Moretta; Andrea De Maria
Journal:  AIDS       Date:  2003-01-24       Impact factor: 4.177

View more
  58 in total

1.  A Subset of Neutrophils Expressing Markers of Antigen-Presenting Cells in Human Visceral Leishmaniasis.

Authors:  Smriti Sharma; Richard E Davis; Shweta Srivastva; Susanne Nylén; Shyam Sundar; Mary E Wilson
Journal:  J Infect Dis       Date:  2016-09-06       Impact factor: 5.226

2.  PTPN22 contributes to exhaustion of T lymphocytes during chronic viral infection.

Authors:  Christian J Maine; John R Teijaro; Kristi Marquardt; Linda A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

3.  Induction of Inhibitory Receptors on T Cells During Plasmodium vivax Malaria Impairs Cytokine Production.

Authors:  Pedro A C Costa; Fabiana M S Leoratti; Maria M Figueiredo; Mauro S Tada; Dhelio B Pereira; Caroline Junqueira; Irene S Soares; Daniel L Barber; Ricardo T Gazzinelli; Lis R V Antonelli
Journal:  J Infect Dis       Date:  2015-05-27       Impact factor: 5.226

4.  Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.

Authors:  Robert G Schaut; Tara L Grinnage-Pulley; Kevin J Esch; Angela J Toepp; Malcolm S Duthie; Randall F Howard; Steven G Reed; Christine A Petersen
Journal:  Vaccine       Date:  2016-09-21       Impact factor: 3.641

5.  Decreased Frequency and Secretion of CD26 Promotes Disease Progression in Indian Post Kala-azar Dermal Leishmaniasis.

Authors:  Shibabrata Mukherjee; Debanjan Mukhopadhyay; Susmita Ghosh; Joyashree N Barbhuiya; Nilay K Das; Mitali Chatterjee
Journal:  J Clin Immunol       Date:  2015-12-07       Impact factor: 8.317

Review 6.  Immunoregulation in human American leishmaniasis: balancing pathology and protection.

Authors:  K J Gollob; A G Viana; W O Dutra
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

7.  Tumor necrosis factor alpha neutralization has no direct effect on parasite burden, but causes impaired IFN-γ production by spleen cells from human visceral leishmaniasis patients.

Authors:  Neetu Singh; Rajiv Kumar; Christian Engwerda; David Sacks; Susanne Nylen; Shyam Sundar
Journal:  Cytokine       Date:  2016-06-30       Impact factor: 3.861

Review 8.  Correlates of GLA family adjuvants' activities.

Authors:  Steven G Reed; Darrick Carter; Corey Casper; Malcolm S Duthie; Christopher B Fox
Journal:  Semin Immunol       Date:  2018-10-23       Impact factor: 11.130

9.  Regulatory IgDhi B Cells Suppress T Cell Function via IL-10 and PD-L1 during Progressive Visceral Leishmaniasis.

Authors:  Robert G Schaut; Ian M Lamb; Angela J Toepp; Benjamin Scott; Carolina O Mendes-Aguiar; Jose F V Coutinho; Selma M B Jeronimo; Mary E Wilson; John T Harty; Thomas J Waldschmidt; Christine A Petersen
Journal:  J Immunol       Date:  2016-04-13       Impact factor: 5.422

Review 10.  Pleiotropic Effect of Hormone Insulin-Like Growth Factor-I in Immune Response and Pathogenesis in Leishmaniases.

Authors:  Luiza C Reis; Eduardo Milton Ramos-Sanchez; Fernanda N Araujo; Ariane F Leal; Christiane Y Ozaki; Orlando R Sevillano; Bernardina A Uscata; Hiro Goto
Journal:  J Immunol Res       Date:  2021-05-04       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.